In vitro generated gemcitabine resistant pancreatic cancer cells were marked by high expression levels of CD44 [191,258], while in another study increased CD24 and ESA expression, as well as activation of the c-MET receptor were also detected in gemcitabine resistant cells [259]. The gene discussed is CD24; the disease is pancreatic neoplasm.